<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ewing sarkomu tedavisi &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/ewing-sarkomu-tedavisi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 18 Jan 2026 21:39:02 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Ewing sarkomu tedavisi &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>KC1036 Diminishes Ewing Sarcoma Tumor Growth Effectively</title>
		<link>https://bioengineer.org/kc1036-diminishes-ewing-sarcoma-tumor-growth-effectively/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 18 Jan 2026 21:38:43 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[anti-angiogenesis]]></category>
		<category><![CDATA[anti-anjiyojenik ilaçlar]]></category>
		<category><![CDATA[Ewing sarkomu tedavisi]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket: **Ewing sarcoma]]></category>
		<category><![CDATA[İşte metin için 5 uygun etiket (virgülle ayrılmış): **KC1036]]></category>
		<category><![CDATA[KC1036]]></category>
		<category><![CDATA[multi-kinase inhibitor]]></category>
		<category><![CDATA[multi-kinaz inhibitörleri]]></category>
		<category><![CDATA[tümör büyüme inhibisyonu** **Açıklama:** 1. **KC1036:** Çalışmanın ana konusu olan spesifik ila]]></category>
		<category><![CDATA[tumor growth inhibition** **Açıklama:** 1. **Ewing sarcoma:** Makalenin odaklandığı spesifik kanser türü. 2. **KC1036:** Araştırmanın merkezindeki deneysel ilaç/bileşik]]></category>
		<guid isPermaLink="false">https://bioengineer.org/kc1036-diminishes-ewing-sarcoma-tumor-growth-effectively/</guid>

					<description><![CDATA[In a groundbreaking study published in the journal Angiogenesis, researchers explored the potential of KC1036, a multi-kinase inhibitor that demonstrates promising anti-angiogenic properties, particularly in the treatment of Ewing sarcoma. Ewing sarcoma is a rare and aggressive bone cancer that primarily affects children and young adults. The study released by a team led by Ou, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318048</post-id>	</item>
	</channel>
</rss>
